CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -32.5% | 15,186 | 0.0% | 0.00% | – |
| Q1 2022 | $40,000 | -25.9% | 15,186 | +83.1% | 0.00% | – |
| Q4 2020 | $54,000 | +575.0% | 8,292 | +761.1% | 0.00% | – |
| Q2 2020 | $8,000 | -97.9% | 963 | -98.1% | 0.00% | -100.0% |
| Q1 2020 | $380,000 | -7.8% | 49,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $412,000 | +9.3% | 49,600 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $377,000 | -34.3% | 51,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $574,000 | +4.4% | 51,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $550,000 | -6.9% | 51,200 | +30.6% | 0.00% | 0.0% |
| Q4 2018 | $591,000 | -18.5% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $725,000 | – | 39,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |